Bryce Point Capital’s Celldex Therapeutics CLDX Stock Holding History

Bryce Point Capital’s Portfolio CLDX Stock Details CLDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell
2025 Q1	$351K	Sell
2024 Q4	$601K	Buy